In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Palisade Bio Inc (NASDAQ: PALI) was $1.74 for the day, up 0.58% from the previous closing price of $1.73. In other words, the price has increased by $0.58 from its previous closing price. On the day, 5.07 million shares were traded. PALI stock price reached its highest trading level at $1.88 during the session, while it also had its lowest trading level at $1.7.
Ratios:
Our analysis of PALI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.55 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PALI now has a Market Capitalization of 231772480 and an Enterprise Value of 10778324.
Stock Price History:
The Beta on a monthly basis for PALI is 1.30, which has changed by -0.5549872 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, PALI has reached a high of $4.32, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 78.06%, while the 200-Day Moving Average is calculated to be 83.02%.
Shares Statistics:
PALI traded an average of 7.73M shares per day over the past three months and 14065050 shares per day over the past ten days. A total of 122.36M shares are outstanding, with a floating share count of 122.34M. Insiders hold about 0.02% of the company’s shares, while institutions hold 47.47% stake in the company. Shares short for PALI as of 1759190400 were 1037875 with a Short Ratio of 0.13, compared to 1756425600 on 335095. Therefore, it implies a Short% of Shares Outstanding of 1037875 and a Short% of Float of 11.41.
Earnings Estimates
. The current rating of Palisade Bio Inc (PALI) reflects the combined expertise of 3.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.32 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$1.55 and -$1.84 for the fiscal current year, implying an average EPS of -$1.72. EPS for the following year is -$1.24, with 3.0 analysts recommending between -$0.72 and -$1.77.
